22 May 2013
Keywords: map, pharma, completes, 30m, finance, round, usa-based
Article | 20 September 2004
USA-based MAP Pharmaceuticals says it has closed a $30 million Series Bpreferred stock financing round, led by Pequot Ventures, Bay City ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.